Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Objective: To compare the treatment costs of insulin glargine (IG; Lantus(®)) to detemir (ID; Levemir(®)), both combined with bolus insulin aspart (NovoRapid(®)) in type 2 diabetes (T2D) in Germany. Methods: Cost comparison was based on data of a 1-year randomised controlled trial [1]. IG was admini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pscherer, Stefan, Dietrich, Eva Susanne, Dippel, Franz-Werner, Neilson, Aileen Rae
Formato: Artigo
Idioma:Inglês
Publicado em: German Medical Science GMS Publishing House 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921814/
https://ncbi.nlm.nih.gov/pubmed/20725588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/000106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados